A randomized controlled trial to test the effectiveness of thymus honey on xerostomia in head and neck cancer patients undergoing radiotherapy
Journal
European Journal of Cancer
Date Issued
September 27, 2015
DOI
10.1016/S0959-8049(16)31576-3
http://dx.doi.org/10.1016/S0959-8049(16)31576-3
Abstract
Introduction: Previous studies have shown that xerostomia is the most frequent complication among patients who receive radiotherapy. The prevalence of xerostomia has been reported to be from 73.5% to 93%. Despite the use of techniques such as sparing the parotid glands and intensity-modulated radiotherapy, xerostomia continues to be cited by patients as a major cause of decreased quality of life (QoL).
Subjects